Why Novo Nordisk A/S (NVO) Stock Fell 3.1% on November 18, 2026
-3.12%$39.43November 18, 2026 · S&P 500 -0.31%
The short answer
Novo Nordisk A/S (NVO) stock is down 3.1% to 39.43 in the November 18, 2026 session. This decline is notably larger than the S&P 500 ETF (SPY), which is down 0.3% during the same session, indicating that the move is likely specific to Novo Nordisk or its industry. Recent headlines, including “Novo Nordisk: The Worst May Be Behind” (SeekingAlpha), suggest that concerns about the company's outlook may be influencing investor sentiment. However, there is no single clear catalyst in the news to explain the stock's movement.
The news behind it
Novo Nordisk: The Worst May Be Behind · SeekingAlpha · Nov 18
Before you buy or sell
Get a second opinion on NVO
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when NVO moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 18, 2026 · What's moving NVO today
Written from that session's quote and the headlines listed above. Educational, not financial advice.